It’s a followup to the Wired article Algorithms Take Control of Wall Street.
It’s a followup to the Wired article Algorithms Take Control of Wall Street.
In June, the American Society of Clinical Oncology (ASCO) hosted its 60th Annual Meeting, drawing over 40,000 attendees from around the globe. This year’s event largely focused on validating revolutionary treatment categories like Chimeric antigen receptor (CAR) T-cell therapies and antibody drug conjugates (ADCs). Given proven clinical benefits across a wider array of cancer types, we expect these novel treatment categories to become increasingly important in the fight against cancer and the growth profiles of select companies in the healthcare space.
Possible Fed policy shift may be weighing on the minds of investors
The twists and turns of trade talks weigh on investors
Like a pilot advising his passengers to keep their seat belts buckled in case of potential air pockets, over the past two days, it seemed advisable to buckle up for a potential pop in volatility. Consider VIX to be the price of parachutes when a plane hits turbulence.